Clinical Trial Update: A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours [Phase 1]

View source ↗

Summary

Phase I, open-label, single-arm dose-escalation study of dichloroacetate in patients with recurrent and/or metastatic solid tumors; the trial status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Dichloroacetate (dichloroacetate)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Neoplasms | Phase 1 | Status: COMPLETED